If you have room for a share or two in your portfolio then take a look at the excellent ASX 200 shares listed below.
Analysts have recently tipped these shares as ones to buy. Here's what you need to know:
Image source: Getty Images
CSL Limited (ASX: CSL)
The first ASX 200 share for investors to look at is CSL. It is one of the world's leading biotechnology companies and the name behind the CSL Behring and Seqirus businesses. Both are leaders in their respective fields of plasma therapies and vaccines.
In addition, the company is in the process of making a major acquisition. It is aiming to acquire Vifor Pharma, which is a leader in iron deficiency, nephrology and cardio-renal therapies, for $16.4 billion.
Citi is a fan of CSL. It recently upgraded the company's shares to a buy rating with a $340.00 price target.
It was pleased with the acquisition of Vifor, commenting: "Because of the large difference in the earnings multiples of both companies and the low cost of debt, we expect the transaction to be double digit NPATA accretive (although ROIC dilutive). The key positive from the transaction is that it expands the CSL late stage R&D pipeline, which we have noted for some time was limited for a company the size of CSL."
Wesfarmers Ltd (ASX: WES)
Another ASX 200 share to look at is Wesfarmers. It is the conglomerate behind several popular retail brands such as Bunnings and Kmart. It also has a diverse portfolio of industrial businesses.
While FY 2022 has been a tough year because of lockdowns and other COVID headwinds, the company looks well-placed for the future thanks to its strong brands, diverse operations, and balance sheet strength. The latter looks set to support M&A activity and the potential expansion into the healthcare sector.
Morgans is very positive on the company. It currently has an add rating and $60.80 price target on its shares.
The broker recently commented: "The company is run by a highly regarded management team and the balance sheet is healthy. While COVID-related staff shortages are proving to be a challenge, the core Bunnings division (>60% of group EBIT) remains a solid performer as consumers continue to invest in their homes. We see the recent pullback in the share price as a good entry point for longer term investors."
